Scott Bizily

Companies

• 4D Molecular Therapeutics, Inc.General counsel Mar 31, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• 4D Molecular Therapeutics, Inc. FDMT8,617 shares²$107.1K at $12.43Sep 16, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 16, 2026Sold 1,635 shares at $13.65 of 4D Molecular Therapeutics, Inc.²
• Sep 16, 2026Exercised options 1,635 shares at $4.14 of 4D Molecular Therapeutics, Inc.²
• Sep 1, 2026Sold 584 shares at $14.00 of 4D Molecular Therapeutics, Inc.³
• Sep 1, 2026Exercised options 584 shares at $6.49 of 4D Molecular Therapeutics, Inc.³
• Aug 17, 2026Sold 1,635 shares at $12.20 of 4D Molecular Therapeutics, Inc.⁴
• Aug 17, 2026Exercised options 1,635 shares at $4.14 of 4D Molecular Therapeutics, Inc.⁴
• Aug 13, 2026Sold 1,635 shares at $12.00 of 4D Molecular Therapeutics, Inc.⁴
• Aug 13, 2026Exercised options 1,635 shares at $4.14 of 4D Molecular Therapeutics, Inc.⁴
• Jun 30, 2026Sold 6,566 shares at $14.00 of 4D Molecular Therapeutics, Inc.⁵
• Jun 30, 2026Exercised options 5,752 shares at $6.49 of 4D Molecular Therapeutics, Inc.⁵
• Jun 30, 2026Exercised options 814 shares at $4.14 of 4D Molecular Therapeutics, Inc.⁵
• Jun 23, 2026Sold 9,810 shares at $12.00 of 4D Molecular Therapeutics, Inc.⁶
• Jun 23, 2026Exercised options 9,810 shares at $4.14 of 4D Molecular Therapeutics, Inc.⁶
• Dec 16, 2025Sold 1,635 shares at $10.90 of 4D Molecular Therapeutics, Inc.⁷
• Dec 16, 2025Exercised options 1,635 shares at $4.14 of 4D Molecular Therapeutics, Inc.⁷
• Nov 17, 2025Sold 1,635 shares at $10.59 of 4D Molecular Therapeutics, Inc.⁸
• Nov 17, 2025Exercised options 1,635 shares at $4.14 of 4D Molecular Therapeutics, Inc.⁸
• Oct 24, 2025Sold 2,678 shares at $12.00 of 4D Molecular Therapeutics, Inc.⁹
• Oct 24, 2025Exercised options 1,084 shares at $6.49 of 4D Molecular Therapeutics, Inc.⁹
• Oct 16, 2025Sold 1,635 shares at $10.17 of 4D Molecular Therapeutics, Inc.¹⁰
• Oct 16, 2025Exercised options 1,635 shares at $4.14 of 4D Molecular Therapeutics, Inc.¹⁰
• Oct 9, 2025Sold 2,408 shares at $10.00 of 4D Molecular Therapeutics, Inc.¹¹
• Sep 23, 2025Sold 2,407 shares at $8.00 of 4D Molecular Therapeutics, Inc.¹²
• Sep 16, 2024Sold 500 shares at $16.33 of 4D Molecular Therapeutics, Inc.¹³
• Sep 16, 2024Exercised options 500 shares at $6.49 of 4D Molecular Therapeutics, Inc.¹³